Whistleblower Accuses CDC of Manipulating Shingles Data with Chickenpox Vaccine
The controversy over varicella vaccine safety and mandates has raged since its introduction in the U.S. nearly 25 years ago. When it was licensed in 1995, the National Vaccine Information Center (NVIC) questioned the strength of the scientific evidence for safety and effectiveness used by CDC and the American Academy of Pediatrics (AAP) to make a universal use recommendation and argued the vaccine should not be mandated because, in part, universal use of the vaccine could drive chickenpox into older children and adults and raise the risks for shingles later in life. Gary S. Goldman, PhD served for eight years as Research Analyst for the Varicella Active Surveillance Project (VASP) in a cooperative project with the CDC. In March 2018, Dr. Gary S. Goldman published an article in Annals of Clinical Pathology, “The US Universal Varicella Vaccination Program: CDC Censorship of Adverse Public Health Consequences.” In that article he provided evidence to support his allegation that CDC officials manipulated varicella data to affirm the CDC’s support for chickenpox vaccine mandates that that will require a lifetime of expensive vaccine boosters. In what Goldman described as a deliberate “attempt to quash the unwanted outcomes in the years following 2000,” he said it became apparent that the methods for interpretation of data were flawed, skewing CDC and VASP conclusions in favor of the varicella mass vaccination program.